ControlMATCH

Select and Match Control Samples Tailored to Your Study

ControlMATCH is a new line of fully annotated control DNA and serum samples designed to help biomedical researchers efficiently validate new biomarkers and early stage clinical trial drug candidates.  Controls and case samples are pre-arranged to be age-, gender-, and ethnicity-matched to accelerate your research efforts.

Leveraging BioServe's Global BioRepository, ControlMATCH allows researchers to select and match control samples to the specific needs of their own DNA and/or serum-based studies.

ControlMATCH DNA and serum controls will initially cover type II diabetes, hypertension and hyperlipidemia.  Other disease states available on a customized basis.  Please contact us.

ControlMATCH normal samples for type II diabetes, hypertension and hyperlipidemia are annotated with:

  • Body Mass Index (BMI),
  • Confirmed normal blood glucose levels,
  • Confirmed normal blood pressure and cholesterol levels,
  • Family history of health status,
  • Ethnicity determined by data collected on three generations.

ControlMATCH permits researchers to identify one-to-one matched controls for extended criteria such as age, gender, ethnicity, BMI, diet and a host of lifestyle factors. Furthermore, ControlMATCH includes clinically confirmed negative results enabling researchers to further confirm that their markers are valued against the correct set of controls.

Interested in a quote? Visit the ControlMATCH Ordering page.

ControlMATCH Customer

Dr Xin Li Wang - ControlMatch Customer
Dr. Xin Li Wang, Baylor College of MEdicine

Dr. Wang, a professor and director in the cardiothoracic research laboratory in the division of cardiothoracic surgery of the Michael E. DeBakey Department of Surgery at Baylor College of Medicine, commented, "We are engaged in landmark cardiothoracic studies that we hope will reveal the DNA aberrations in a few target genes responsible for thoracic aortic disease. Like any large epidemiological study, time is money and generating valid results as quickly as possible is a prerequisite for success."

"The faster a study is able to generate validated results, the higher the probability of achieving longer term program milestones. By providing us with ready made DNA samples stratified by age, ethnicity and smoking status, BioServe™'s ControlMATCH has proven to be an indispensable tool in accelerating our research," he added.